1.
Eight-year-old survives rabies
SALT LAKE CITY, Nov. 16 (UPI) -- A new drug undergoing a clinical trial at the University of Utah could help some cystic fibrosis patients' daily life and longevity, researchers said.
Cystic fibrosis is a genetic condition that causes cells to improperly manufacture a protein resulting in the production of a thick, sticky mucus that clogs and damages lungs and causes digestion problems.
Traditional cystic fibrosis drugs treat the symptoms of digestion problems and lung mucus buildup.
However, the new drug VX-770 would prevent mucus from forming in the first place. For younger patients, or those with milder cases, the drug could provide the closest thing to a cure, the Salt Lake City Tribune reported Monday.
The trial for VX-770 focuses on a mutation that affects only about 2 percent of the people with cystic fibrosis, but the researchers say they hope they could adapt the drug to work for a wider population.
|
|
|
| Additional Health News Stories | |
ANTALYA, Turkey, Feb. 8 (UPI) --
A Turkish court Wednesday began hearing the case of a mother and father accused of sexually assaulting their two teenage daughters.
|
LOS ANGELES, Feb. 8 (UPI) --
Pop star Katy Perry and comedian Russell Brand informed Los Angeles Superior Court they have reached a settlement in their divorce, documents show.
|
KARACHI, Pakistan, Feb. 8 (UPI) --
Experts said the carcass of a giant whale shark that washed ashore at Pakistan's Karachi Harbor likely got lost and became trapped in the shallow waters.
|
TROLLHATTAN, Sweden, Feb. 8 (UPI) --
Insolvent Swedish automobile company Saab has attracted potential buyers, said a bankruptcy trustee, who did not want to reveal names.
|
| Stories | Photos | People | Comments |
View Caption
